Haloperidol versus risperidone for schizophrenia

3Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To review the clinical effectiveness and safety of haloperidol compared with risperidone for people with schizophrenia.

Cite

CITATION STYLE

APA

Ray, S., Ray, A., Gopi, A., & Hunter, R. (2017). Haloperidol versus risperidone for schizophrenia. Cochrane Database of Systematic Reviews, 2017(7). https://doi.org/10.1002/14651858.CD012728

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free